Literature DB >> 29805525

miR-128 induces pancreas cancer cell apoptosis by targeting MDM4.

Hongchao Han1, Lisheng Wang1, Jie Xu2, Aikun Wang1.   

Abstract

MicroRNAs (miRNA/miRs) are small, non-coding RNA molecules (19-25 nucleotides in length), which function to regulate gene expression. It has been reported that miR-128 serves an important role in regulating cancer cell growth; increasing evidence has indicated that the expression of miR-128 is decreased in pancreatic cancer (PC) cells. However, the specific mechanisms of miR-128 in regulating PC cell growth are unclear. In the present study, it was confirmed that the expression of miR-128 was significantly decreased within PC tissues compared with adjacent normal tissues via reverse transcription-quantitative polymerase chain reaction analysis. In addition, miR-128 mimics inhibited PC MIA-PaCa2 cell growth by enhancing cell apoptosis in a caspase-dependent manner. Furthermore, the results of the present study demonstrated that double minute 4 (MDM4) may be a direct target for miR-128 via a dual luciferase report assay; miR-128 may inhibit MDM4 expression, and increase p53 and cleaved caspase-3 protein expression levels. In summary, the present study indicated that miR-128 is downregulated in PC, and it may be a promising target for future PC diagnosis and treatment.

Entities:  

Keywords:  cell growth; double minute 4; microRNA; p53; pancreatic cancer

Year:  2018        PMID: 29805525      PMCID: PMC5958784          DOI: 10.3892/etm.2018.6047

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

3.  Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.

Authors:  Shuyu Zhang; Jun Hao; Fang Xie; Xiangui Hu; Cong Liu; Jian Tong; Jundong Zhou; Jinchang Wu; Chenghao Shao
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

Review 4.  Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

Authors:  Satyanarayana Rachagani; Muzafar A Macha; Nicholas Heimann; Parthasarathy Seshacharyulu; Dhanya Haridas; Seema Chugh; Surinder K Batra
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

5.  MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.

Authors:  Jun Hao; Shuyu Zhang; Yingqi Zhou; Xiangui Hu; Chenghao Shao
Journal:  FEBS Lett       Date:  2010-11-27       Impact factor: 4.124

Review 6.  Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy.

Authors:  Jeremy L Davis; Prakash K Pandalai; R Taylor Ripley; Russell C Langan; Itzhak Avital
Journal:  Pancreas       Date:  2012-07       Impact factor: 3.327

7.  Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results.

Authors:  Joseph M Herman; Aaron T Wild; Hao Wang; Phuoc T Tran; Kenneth J Chang; Gretchen E Taylor; Ross C Donehower; Timothy M Pawlik; Mark A Ziegler; Hongyan Cai; Dionne T Savage; Marcia I Canto; Jason Klapman; Tony Reid; Raj J Shah; Sarah E Hoffe; Alexander Rosemurgy; Christopher L Wolfgang; Daniel A Laheru
Journal:  J Clin Oncol       Date:  2013-01-22       Impact factor: 44.544

8.  Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer.

Authors:  Makoto Abue; Misa Yokoyama; Rie Shibuya; Keiichi Tamai; Kazunori Yamaguchi; Ikuro Sato; Nobuyuki Tanaka; Shin Hamada; Tooru Shimosegawa; Kazuo Sugamura; Kennichi Satoh
Journal:  Int J Oncol       Date:  2014-11-10       Impact factor: 5.650

Review 9.  Advance in microRNA as a potential biomarker for early detection of pancreatic cancer.

Authors:  Jing Huang; Jianzhou Liu; Kevin Chen-Xiao; Xuemei Zhang; W N Paul Lee; Vay Liang W Go; Gary Guishan Xiao
Journal:  Biomark Res       Date:  2016-10-22

10.  MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer.

Authors:  S Ali; H Saleh; S Sethi; F H Sarkar; P A Philip
Journal:  Br J Cancer       Date:  2012-08-28       Impact factor: 7.640

View more
  10 in total

Review 1.  Potential role of microRNAs in pancreatic cancer manifestation: a review.

Authors:  Lisa Kabiraj; Atreyee Kundu
Journal:  J Egypt Natl Canc Inst       Date:  2022-06-20

2.  LINC02381-ceRNA exerts its oncogenic effect through regulation of IGF1R signaling pathway in glioma.

Authors:  Hossein Nemati; Masoumeh Fakhre-Taha; Amir-Reza Javanmard; Amin Jahanbakhshi; Seyed Javad Mowla; Bahram M Soltani
Journal:  J Neurooncol       Date:  2022-04-23       Impact factor: 4.130

Review 3.  MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.

Authors:  Jin Wu; Guanting Lu; Xinjiang Wang
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

4.  Pseudogene MSTO2P Interacts with miR-128-3p to Regulate Coptisine Sensitivity of Non-Small-Cell Lung Cancer (NSCLC) through TGF-β Signaling and VEGFC.

Authors:  Minwei Gu; Xinlian Wang
Journal:  J Oncol       Date:  2022-06-26       Impact factor: 4.501

5.  MiRNA-128 and MiRNA-142 Regulate Tumorigenesis and EMT in Oral Squamous Cell Carcinoma Through HOXA10.

Authors:  Yao Yao; Qian Xu; Liyong Yan; Yan Jiao; Qingqi Su; Xiaoguang Li; Cong Liu; Feng Zhao
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

6.  B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration.

Authors:  Xiaomao Hu; Minxian Xu; Yangzhi Hu; Na Li; Lei Zhou
Journal:  Cell Biochem Biophys       Date:  2021-03-20       Impact factor: 2.194

7.  Elevation in the Expression of circ_0079586 Predicts Poor Prognosis and Accelerates Progression in Glioma via Interactions with the miR-183-5p/MDM4 Signaling Pathway.

Authors:  Jingyu Chen; Tianyi Liu; Hui Wang; Zhipeng Wang; Yanju Lv; Yuying Zhao; Ning Yang; Xueli Yuan
Journal:  Onco Targets Ther       Date:  2020-06-08       Impact factor: 4.147

8.  MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.

Authors:  Chengbin Zhao; Ruiming Guo; Fangxia Guan; Shanshan Ma; Mu Li; Junru Wu; Xianzhi Liu; Hongwei Li; Bo Yang
Journal:  Sci Rep       Date:  2020-06-11       Impact factor: 4.379

9.  PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression.

Authors:  Sumit Agarwal; Balabhadrapatruni V S K Chakravarthi; Hyung-Gyoon Kim; Nirzari Gupta; Kevin Hale; Sai Akshaya Hodigere Balasubramanya; Patsy G Oliver; Dafydd G Thomas; Isam-Eldin A Eltoum; Donald J Buchsbaum; Upender Manne; Sooryanarayana Varambally
Journal:  Transl Oncol       Date:  2020-05-15       Impact factor: 4.243

10.  A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer.

Authors:  Jinchang Pan; Chengwei Zhou; Xiaodong Zhao; Jinxian He; Hui Tian; Weiyu Shen; Ying Han; Jun Chen; Shuai Fang; Xiaodan Meng; Xiaofeng Jin; Zhaohui Gong
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.